Emepepimut-S for non-small cell lung cancer. - Wikidata - wikimedia - TriplyDB

Emepepimut-S for non-small cell lung cancer.

Emepepimut-S for non-small cell lung cancer.

http://www.wikidata.org/entity/Q37891983

about

MUC1 peptide vaccine mediated antitumor activity in non-small cell lung cancer Challenges and opportunities for cancer vaccines in the current NSCLC clinical scenario.

P2860

Q35093118-1459AFA4-CC92-4C0C-8805-A0D7B35745C3 Q38143201-328891BD-8750-4826-BD7F-49DC2286387E

P2860

Emepepimut-S for non-small cell lung cancer.

http://www.wikidata.org/entity/Q37891983

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 June 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Emepepimut-S for non-small cell lung cancer.

@en

Emepepimut-S for non-small cell lung cancer.

@nl

type

label

Emepepimut-S for non-small cell lung cancer.

@en

Emepepimut-S for non-small cell lung cancer.

@nl

prefLabel

Emepepimut-S for non-small cell lung cancer.

@en

Emepepimut-S for non-small cell lung cancer.

@nl

P1433

Q37891983-E6120FFC-9D68-4ABF-A3FA-9610A43931D9

P1476

Q37891983-2A65D756-A6D9-4344-9C65-C2A107B0B4BD

P2093

Q37891983-75928033-A5D6-4E7C-8893-46659048C918

Q37891983-F1C763A5-3B7B-433C-8FF2-2965CC37DF0E

Q37891983-F2A62ECB-96F7-47C9-A278-8034064C6B71

P2860

Q37891983-03AC03BB-8F32-4216-B20F-33257D0B31B5

Q37891983-194D0CCA-FD23-4899-B7FD-2B19E8E920BC

Q37891983-1EDB7F4C-D6CF-4DFE-833F-77CBA166E0A4

Q37891983-1F751690-B9CE-44A4-9B6D-2AA0DC7CC516

Q37891983-1FEA1B53-6510-4755-9AA0-B5B54908AADC

Q37891983-4569A7D7-8628-43E0-A9F0-8B4A831A7BD4

Q37891983-532310D0-F163-43A7-AF12-73A5CBD434C4

Q37891983-5376E55D-717A-4871-BCCE-8A2461D7C9F8

Q37891983-60C9F03D-6080-46F1-A8F1-5FEEF97A20E5

Q37891983-6292D255-21D9-44BB-A1EE-3CF803A21307

P304

Q37891983-9D7DCA2E-BCA6-4096-A9F3-7B12F6FCEB3C

P31

Q37891983-E5A7FB77-5A28-4BFD-8F28-98B0EB7F314F

P356

Q37891983-7C7228D5-37C4-4C7A-A7A1-6CE616C070A2

P407

Q37891983-53059CD8-177E-4C75-A097-18292774D190

P433

Q37891983-09075D42-7CBE-4793-8119-E353F62AE9FA

P478

Q37891983-23DB356A-8EA3-4900-868C-62D8F8486137

P577

Q37891983-EDDA150E-8179-469D-BFC6-2CBAE2073429

P698

Q37891983-C84CF70D-4F7B-4CC1-BBC0-A892C7A004D7

P356

14712598.2011.592490

P1433

Expert Opinion on Biological Therapy

P1476

Emepepimut-S for non-small cell lung cancer.

@en

P2093

Denis Soulières

http://www.w3.org/2001/XMLSchema#string

Luis Corrales-Rodriguez

http://www.w3.org/2001/XMLSchema#string

Normand Blais

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Global cancer statistics, 2002

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Inflammation and cancer: back to Virchow?

Going up or coming down? The changing phases of the lung cancer epidemic from 1967 to 1999 in the 15 European Union countries

Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control

The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature.

MUC1 is a novel regulator of ErbB1 receptor trafficking.

Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes.

L-BLP25: a peptide vaccine strategy in non small cell lung cancer.

P304

1091-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2011.592490

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21689064

http://www.w3.org/2001/XMLSchema#string